University of Colorado Cancer Center Support Grant

摘要 UCCC是科罗拉多唯一一家NCI指定的癌症中心，其服务范围覆盖整个科罗拉多州 在科罗拉多。从概念上讲，有两个“科罗拉多州”：前山脉（包括丹佛大都市区 沿着一系列的郊区和城市地区从英尺。北部的柯林斯到南部的普韦布洛）; 科罗拉多，那里有23.1%的人口。这个州的种族和民族是多样化的， 占2019年人口的21.8%，居住在全州，其中22.1%的城市人口 11.6%的农村人口是西班牙裔。科罗拉多最偏远的农村地区是 最贫穷的西班牙裔美国人同样，科罗拉多的非洲裔美国人（占总人口的4%） 贫困人口比例过高，生活在偏远的农村和边境县。Our National Outreach Network（NON） 社区健康教育者（CHE）[NON-CHE]项目组织和开展活动，覆盖所有人 科罗拉多人，但特别是农村，西班牙裔和贫困人口。通过非CHE项目， 我们专注于教育社区参与CT和预防癌症的重要性， 与HPV疫苗相关的疾病。我们还实施文化定制的外联活动，以加强 社区成员对当地可用的CT和HPV疫苗的了解、查询和参与。我们 该项目的重点是确定社区成员并将其转介给卫生保健提供者/机构， 在附属机构提供CT。为了进行评估，我们跟踪了转诊到医疗保健机构的人数 CT参与的提供者/机构，转诊后3个月随访，以确定个人是否 接受或拒绝CT参与，并记录个人决定不参与CT的原因。 同样，我们开展外展活动，向患者宣传HPV疫苗，并将他们转介到疫苗接种服务机构。 与位于科罗拉多丹佛的联邦合格健康中心（FHC）合作。对于我们的CT和 HPV疫苗倡议，我们已经制定和传播文化，语言（英语和西班牙语）， 扫盲适当的信息，以增加种族/族裔多样性社区的知识和认识。 我们还专注于提供有关治疗服务的信息，并让患者参与医疗决策 为患者量身定制。(i.e.,风险和遗传易感性）。最后，我们还提供社区 演讲，以获得广泛的接触和参与。 有了这个补充扩展，我们计划继续我们的倡议，通过与农村合作伙伴关系， 对青少年（11-18岁）和年轻人的父母进行癌症教育的差距扩大的县 (aged 19-26）关于HPV疫苗的重要性，并引导符合条件的患者获得HPV疫苗 接种者需要完成推荐的HPV疫苗接种计划。此外，我们将包括一个 娱乐教育（E-E）视频，让父母和年轻人参与基于证据的 影响前体的干预（例如，接种HPV疫苗的目的。

Abstract The UCCC is the only NCI-designated Cancer Center in Colorado and has as its catchment area the entire State of Colorado. There are conceptually two ‘Colorados’: the Front Range (including the Denver metropolitan area along with a string of suburban and urban areas from Ft. Collins in the north to Pueblo in the south); and rural Colorado, where 23.1% of the population lives. The state is racially and ethnically diverse with Hispanics comprising 21.8% of the population in 2019 and residing throughout the state, where 22.1% of the urban population and 11.6% of the rural population are Hispanic. Colorado’s most isolated rural areas are home to the poorest Hispanics in the State. Likewise, Colorado’s African American population (4% of the total) is disproportionately poor and lives in isolated rural and frontier counties. Our National Outreach Network’s (NON) Community Health Educators (CHE) [NON-CHE] project organizes and conduct activities to reach all Coloradans, but in particular rural, Hispanic, and poverty-stricken populations. Through the NON-CHE project, we focus on educating communities about the importance of participating in CT and preventing cancers associated with the HPV with HPV vaccines. We also implement culturally tailored outreach activities to enhance community members’ knowledge of, inquiry, and participation in locally available CT and HPV vaccinations. Our project focuses on identifying and referring community members to health care providers/institutions with available CT at affiliated institutions. For evaluation, we track the number of individuals referred to health care providers/institutions for CT participation with a 3-month post-referral follow-up to determine whether individuals accepted or declined CT participation and record reasons why individuals decided not to participate in a CT. Similarly, we conduct outreach to educate patients about the HPV vaccine and refer them to vaccination services in partnership with a Federally Qualified Health Center (FQHC) in Denver, Colorado. For both of our CT and HPV vaccine initiatives, we have developed and disseminate culturally, linguistically (English and Spanish), and literacy appropriate information to increase knowledge and awareness of racially/ethnically diverse communities. We also focus on providing information about treatment services and engaging patients in medical decision-making tailored to the individual patient. (i.e., risk and genetic predisposition). Last, we also provide community presentations for great reach and engagement. With this supplement extension we plan to continue our initiative by partnering with a rural FQHC that serves counties with increased cancer disparities to educate parents of adolescents (aged 11-18) and young adults (aged 19-26) about the importance of the HPV vaccine and navigate eligible patients to obtain the HPV vaccine doses need to complete their recommended HPV vaccine schedules. In addition, we will include an entertainment-education (E-E) video for parents and young adults to engage them in an evidence-based intervention to affect the precursors (e.g., intentions) to adopting of the HPV vaccine.